The use of fixed-mixture insulins in clinical practice

European Journal of Clinical Pharmacology

Volumn 56, Issue 1, 2000, Pages 19-25

  Turner, H E ^a   Matthews, D R ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Glycaemic control; Insulin fixed mixture; Premixed insulins

Indexed keywords

INSULIN; INSULIN DERIVATIVE; INSULIN LISPRO; ISOPHANE INSULIN;

AGING; ARTICLE; CLINICAL PRACTICE; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG FORMULATION; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PRIORITY JOURNAL;

EID: 0034115480     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050715     Document Type: Article

References (46)

1. 1. Anonymous (1996) Intercontinental Medical Statistics. Based on IMS database 1996
2. 2. DCCT Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986
3. 3. Ohkubo Y, Kishikawa H, Araki A, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Schichiri M (1995) Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus: a randomised prospective 6 year study. Diabetes Res Clin Pract 28: 103-117
4. 4. American Diabetes Association (1996) The pharmacological treatment of hyperglycaemia in NIDDM. Diabetes Care 19: S54-S61
5. 5. UK Prospective Diabetes Study Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-854
6. 6. Rowland J (1984) Need stable diabetics mix their insulins? Diabet Med 1: 51-53
7. 7. Dunbar J, Madden P, Gleeson D, Fiad T, Mckenna T (1994) Premixed insulin preparations in pen syringes maintain glycaemic control and are preferred by patients. Diabetes Care 17: 874-878
8. 8. Oakley N, Mather H, Hadley L, Lynch J, Pilkinton T (1981) Twice daily insulin regimens in management of severe diabetes. J R Soc Med 74: 363-367
9. 9. Bell D, Clements R, Perentesis G, Roddam R, Wagennecht L (1991) Dosage accuracy of self-mixed versus premixed insulin. Arch Int Med 151: 2265-2269
10. 10. Berne C, Eriksson G, Lundgren P (1986) How accurate are insulin mixtures prepared by the patients? Diabetes Care 9: 23-26
11. 11. Corcoran J, Yudkin J (1985) How inaccurate is insulin mixing? Patient variability and syringe dead space effect. Diabet Med 2: 131-133
12. 12. Cucinotta D, Mannino D, Lasco A, Di Cesare E, Musolino C, Alessi R (1991) Premixed insulin at ratio 3/7 and regular + isophane insulins at mixing ratios from 2/8 to 4/6 achieve the same metabolic control. Diabetes Metab 17: 49-54
13. 13. Perentesis G, Clements R, Jr (1990) Accuracy of two new insulin injection devices. Diabetes 30: 176A
14. 14. Corcoran J, Yudkin J (1986) A comparison of pre-mixed with patient mixed insulins. Diabet Med 3: 246-249
15. 15. Khachadurian A, Davidson J, Braunstein S, Redmond G, Greefield M, Lauritano A, Haycock P (1989) Comparison of fixed-ratio versus variable-ratio regular and NPH semisynthetic human insulin-requiring diabetic patients. Clin Ther 11: 485-494
16. 16. Aronoff S, Goldberg R, Kumar D, Lichtenstein E, Schwartz S, Sosenko J (1994) Use of a premixed insulin regimen (Novolin 70/30) to replace self-mixed insulin regimens. Clin Ther 16: 41-49
17. 17. Bell D, Cutter G, Lauritano A (1989) Efficacy of a pre-mixed semisynthetic human insulin regimen. Clin Ther 11: 795-801
18. 18. Galloway J, Spradlin C, Nelson R, Wentworth S, Davidson J, Swarner J (1981) Factors influencing the absorption, serum insulin concentration, and blood glucose responses after injections of regular insulin and various mixtures. Diabetes Care 4: 366-376
19. 19. Brodows R, Chessor R (1995) A comparison of pre-mixed insulin preparations in elderly patients. Diabetes Care 18: 855-857
20. 20. Woodworth J, Rowe H, Howey D, Compton J, Bowsher R, Cerimele B, Brunelle R (1994) Comparative pharmacokinetics and glucodynamics of 2 human insulin mixtures. Diabetes Care 17: 366-371
21. 21. Owens D, Jones A, Dolben J, Dean J, Petocz P, Coates P, Luzio S (1993) The pharmacokinetics of five pre-mixed combinations of 'short-' and 'intermediate-acting' (NPH) insulins in healthy subjects following subcutaneous administration. Diabetes Res 22: 77-86
22. 22. Owens D, Vora J, Jones I, Birtwell J, Atiea J, Luzio S, Williams S (1988) Soluble and lente human insulin mixtures in normal man. Diabetes Res 7: 35-40
23. 23. Olsson P, Hans A, Henning V (1987) Miscibility of human semisynthetic regular and lente insulin and human biosynthetic regular and NPH insulin. Diabetes Care 10: 473-477
24. 24. Klauser R, Schernthaner G, Prager R (1988) Mixtures of human intermediate and human regular insulin in type 1 diabetic patients. Diabetes Res Clin Pract 5: 185-190
25. 25. Heine R, Bilo H, Fonk T, Van De Meer J (1984) Absorption kinetics and action profiles of mixtures of short and intermediate acting insulin. Diabetologia 27: 558-562
26. 26. Davis S, Thompson C, Brown M, Home P, Alberti K (1991) A comparison of the pharmacokinetics and metabolic effects of human regular and NPH insulin mixtures. Diabetes Res Clin Pract 13: 107-118
27. 27. Goldberg A, Coon P (1987) Non-insulin-dependent diabetes mellitus in the elderly. Endocrinol Metab Clin North Am 16: 843-865
28. 28. UK Prospective Diabetes Study Group (1995) UK Prospective Diabetes Study 16: overview of six years' therapy of type 2 diabetes - a progressive disease. Diabetes 44: 1249-1258
29. 29. Wolffenbuttel B, Sels J, Rondas-Colbers G, Menheere P, Kruseman A (1996) Comparison of different insulin regimens in elderly patients with NIDDM. Diabetes Care 19: 1325-1332
30. 30. Yki Jarvinen H, Kauppila M, Kujansuu E, Lahti J, Marjanen T, Niskanen L, Rajala S, Ryysy L, Salo S, Seppala P, et al. (1992) Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 327: 1426-1433
31. 31. Coscelli C, Calabrese G, Fedele D, Pisu E, Calderini C, Bistoni S, Lapolla A, Mauri M, Rossi A, Zappella A (1992) Use of premixed insulin among the elderly. Diabetes Care 15: 1628-1630
32. 32. Gardner S, Bingley P, Sawtell P, Weeks S, Gale E (1997) Rising incidence of insulin dependent diabetes in children aged under 5 years in the Oxford region: time trend analysis. The Bart's-Oxford Study Group. BMJ 314: 713-717
33. 33. O'Hagen M, Greene S (1993) Pre-mixed insulin delivered by disposable pen in the management of children with diabetes. Diabet Med 10: 972-975
34. 34. Riddle M (1992) Combined therapy for diabetes. Postgrad Med 92: 89-102
35. 35. Ravnik-Oblak M, Mrevlje F (1995) Insulin versus a combination of insulin and sulphonylurea in the treatment of NIDDM patients with secondary oral failure. Diabetes Res Clin Pract 30: 27-35
36. 36. Riddle M, Hart J, Bingham P, Garrison C, McDaniel P (1992) Combined therapy for obese type 2 diabetes: suppertime mixed insulin with daytime sulphonylurea. Am J Med Sci 303: 151-156
37. 37. Anderson J, Brunelle R, Koivisto V, Pfutzner A, Trautmann M, Vignati L, DiMarchi R (1997) Reduction of postprandial hyperglycaemia and frequency of hypoglycaemia in IDDM patients on insulin-analog treatment. Multicentre Insulin Lispro Study Group. Diabetes 46: 265-270
38. 38. Holleman F, Hoekstra J (1997) Insulin lispro. N Engl J Med 337: 176-183
39. 39. Ebeling P, Jansson P, Smith U, Lalli C, Bolli G, Koivisto V (1997) Strategies toward improved control during insulin lispro therapy in IDDM. Importance of basal insulin. Diabetes Care 20: 1287-1289
40. 40. Zinman B, Tildesley H, Chiasson J, Tsui E, Strack T (1997) Insulin lispro in CSII: results of a double-blind crossover study. Diabetes 46: 440-443
41. 41. Del-Sindaco P, Ciofetta M, Lalli C, Perriello G, Pampanelli S, Torlone E, Brunetti P, Bolli G (1998) Use of the short acting insulin analogue lispro in intensive treatment of type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time-interval injection-meal. Diabet Med 15: 592-600
42. 42. Ahmed A, Home P (1998) Optimal provision of daytime NPH insulin in patients using the insulin analogue lispro. Diabetes Care 21: 1707-1713
43. 43. Burge M, Waters D, Holcombe J, Schade D (1997) Prolonged efficacy of short acting insulin lispro in combination with human ultralente in insulin dependent diabetes mellitus. J Clin Endocrinol Metab 82: 920-924
44. 44. Torlone E, Papanelli S, Lalli C, et al. (1996) Effects of short acting insulin analog (Lys(B28), Pro (B29)) on postprandial blood glucose control in IDDM. Diabetes Care 19: 945-952
45. 45. Radzuik J, Bradley B, Welsh L, De Fellipis M, Roach P (1996) Neutral protamine lispro: activity profile of s.c. administration with and without admixture of soluble lispro. Diabetologia 39: A224
46. 46. Heise T, Weyer C, Serwas A, Heinrichs S, Osinga J, Roach P, Woodworth J, Gudat U, Heinemann L (1998) Time-action profiles of novel pre-mixed preparations of insulin lispro and NPL insulin. Diabetes Care 21: 800-803